financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
Evotec's Biologics Segment Expands Sandoz Partnership
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Evotec's Biologics Segment Expands Sandoz Partnership
Jul 8, 2024 7:11 AM

09:51 AM EDT, 07/08/2024 (MT Newswires) -- Evotec (EVO) biologics segment Just - Evotec Biologics expanded collaboration with Sandoz to receive remuneration tied to early scientific validation and further funding upon achieving development milestones from 2025, Evotec said Monday.

Financial details were not disclosed.

Shares of Evotec were up more than 2% in early Monday trading.

Price: 5.44, Change: +0.14, Percent Change: +2.55

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alnylam Pharmaceuticals Insider Sold Shares Worth $422,144, According to a Recent SEC Filing
Alnylam Pharmaceuticals Insider Sold Shares Worth $422,144, According to a Recent SEC Filing
Nov 27, 2024
05:29 PM EST, 11/27/2024 (MT Newswires) -- Pushkal Garg, CMO & EVP Dev & Med Affairs, on Nov. 25 and Nov. 26, sold 1,682 shares in Alnylam Pharmaceuticals ( ALNY ) for $422,144. Following the Form 4 filing with the SEC, Garg has control over a total of 18,138 shares of the company, with 17,457 shares held directly and 681...
 Atlassian Insider Sold Shares Worth $2,080,255, According to a Recent SEC Filing
Atlassian Insider Sold Shares Worth $2,080,255, According to a Recent SEC Filing
Nov 27, 2024
05:30 PM EST, 11/27/2024 (MT Newswires) -- Michael Cannon-Brookes, 10% Owner, Director, CEO, Co-Founder, on Nov. 27, sold 7,948 shares in Atlassian ( TEAM ) for $2,080,255. Following the Form 4 filing with the SEC, Cannon-Brookes has control over a total of 174,856 shares of the company, with 174,856 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218024008022/xslF345X05/primarydocument.xml ...
 Cricut Insider Sold Shares Worth $413,221, According to a Recent SEC Filing
Cricut Insider Sold Shares Worth $413,221, According to a Recent SEC Filing
Nov 27, 2024
05:31 PM EST, 11/27/2024 (MT Newswires) -- Arora Ashish, 10% Owner, Director, Chief Executive Officer, on Nov. 25 and Nov. 26, sold 78,095 shares in Cricut ( CRCT ) for $413,221. Following the Form 4 filing with the SEC, Ashish has control over a total of 3,957,038 shares of the company, with 3,957,038 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1828962/000182896224000131/xslF345X05/wk-form4_1732746095.xml ...
 Alnylam Pharmaceuticals Insider Sold Shares Worth $1,309,853, According to a Recent SEC Filing
Alnylam Pharmaceuticals Insider Sold Shares Worth $1,309,853, According to a Recent SEC Filing
Nov 27, 2024
05:29 PM EST, 11/27/2024 (MT Newswires) -- Yvonne Greenstreet, Director, Chief Executive Officer, on Nov. 25 and Nov. 26, sold 5,219 shares in Alnylam Pharmaceuticals ( ALNY ) for $1,309,853. Following the Form 4 filing with the SEC, Greenstreet has control over a total of 79,287 shares of the company, with 78,880 shares held directly and 407 controlled indirectly. SEC...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved